Luster M - Search Results

1

Changing trends of incidence and prognosis of thyroid carcinoma in lower Franconia, Germany, from 1981-1995.

Farahati J, Geling M, Mäder U, Mörtl M, Luster M, Müller JG, Flentje M, Reiners C. Farahati J, et al. Among authors: luster m. Thyroid. 2004 Feb;14(2):141-7. doi: 10.1089/105072504322880382. Thyroid. 2004. PMID: 15068629

2

[Reduction of thyroid volume following radioiodine therapy for functional autonomy].

Luster M, Jacob M, Thelen MH, Michalowski U, Deutsch U, Reiners C. Luster M, et al. Nuklearmedizin. 1995 Apr;34(2):57-60. Nuklearmedizin. 1995. PMID: 7761274 German.

3

Effect of small doses of iodine on thyroid function in patients with Hashimoto's thyroiditis residing in an area of mild iodine deficiency.

Reinhardt W, Luster M, Rudorff KH, Heckmann C, Petrasch S, Lederbogen S, Haase R, Saller B, Reiners C, Reinwein D, Mann K. Reinhardt W, et al. Among authors: luster m. Eur J Endocrinol. 1998 Jul;139(1):23-8. doi: 10.1530/eje.0.1390023. Eur J Endocrinol. 1998. PMID: 9703374 Clinical Trial.

4

Clinical experience with recombinant human thyroid-stimulating hormone (rhTSH): whole-body scanning with iodine-131.

Reiners C, Luster M, Lassmann M. Reiners C, et al. Among authors: luster m. J Endocrinol Invest. 1999;22(11 Suppl):17-24. J Endocrinol Invest. 1999. PMID: 10727001 Review.

5

The use of recombinant human TSH in a patient with metastatic follicular carcinoma and insufficient endogenous TSH production.

Luster M, Reinhardt W, Korber C, Lassmann M, Haenscheid H, Michalowski U, Rendl J, Eising E, Mann K, Reiners C. Luster M, et al. J Endocrinol Invest. 2000 Jul-Aug;23(7):473-5. doi: 10.1007/BF03343758. J Endocrinol Invest. 2000. PMID: 11005273

6

Use of recombinant human thyrotropin before radioiodine therapy in patients with advanced differentiated thyroid carcinoma.

Luster M, Lassmann M, Haenscheid H, Michalowski U, Incerti C, Reiners C. Luster M, et al. J Clin Endocrinol Metab. 2000 Oct;85(10):3640-5. doi: 10.1210/jcem.85.10.6903. J Clin Endocrinol Metab. 2000. PMID: 11061516 Clinical Trial.

7

[Patient selection criteria for single-sided or minimal invasive operative procedures in primary hyperparathyroidism (pHPT)].

Timm S, Hamelmann W, Luster M, Reiners C, Geling M, Thiede A, Timmermann W. Timm S, et al. Among authors: luster m. Zentralbl Chir. 2002 May;127(5):443-7. doi: 10.1055/s-2002-31975. Zentralbl Chir. 2002. PMID: 12058306 German.

8

Comparison of radioiodine biokinetics following the administration of recombinant human thyroid stimulating hormone and after thyroid hormone withdrawal in thyroid carcinoma.

Luster M, Sherman SI, Skarulis MC, Reynolds JR, Lassmann M, Hänscheid H, Reiners C. Luster M, et al. Eur J Nucl Med Mol Imaging. 2003 Oct;30(10):1371-7. doi: 10.1007/s00259-003-1230-1. Epub 2003 Jul 15. Eur J Nucl Med Mol Imaging. 2003. PMID: 12856155 Clinical Trial.

9

Impact of 131I diagnostic activities on the biokinetics of thyroid remnants.

Lassmann M, Luster M, Hänscheid H, Reiners C. Lassmann M, et al. Among authors: luster m. J Nucl Med. 2004 Apr;45(4):619-25. J Nucl Med. 2004. PMID: 15073258 Free article. Clinical Trial.

10

Real time RT-PCR analysis of thyroglobulin mRNA in peripheral blood in patients with congenital athyreosis and with differentiated thyroid carcinoma after stimulation with recombinant human thyrotropin.

Kaufmann S, Schmutzler C, Schomburg L, Körber C, Luster M, Rendl J, Reiners C, Köhrle J. Kaufmann S, et al. Among authors: luster m. Endocr Regul. 2004 Jun;38(2):41-9. Endocr Regul. 2004. PMID: 15497927

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

525 results

Search Page

Filters